AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Rivaroxaban 2.5 Mg ;
9 registrations across 1 African market— 9 active
Markets with Rivaroxaban 2.5 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Kemiroxaban 2.5 mg Film Coated Tablets | 🇪🇬Egypt | Chemipharm Pharmaceutical Industries | active | — |
| Rivaxarelt 2.5 mg Film Coated Tablets | 🇪🇬Egypt | penta pharma egypt | active | — |
| Xanoxiban 2.5 mg Film Coated Tablets | 🇪🇬Egypt | Hikma pharma | active | — |
| Vaxato 2.5 mg Film Coated Tablets | 🇪🇬Egypt | The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA" | active | — |
| Repatoxaban 2.5 mg Film Coated Tablets | 🇪🇬Egypt | EVAPHARMA for Pharmaceutical Industries ( EVAPHARMA) | active | — |
| Vaxato 2.5 mg Film Coated Tablets | 🇪🇬Egypt | The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA" | active | — |
| Orgoroxaban 2.5 mg Film Coated Tablets | 🇪🇬Egypt | organo for pharmaceutical and chemical industries (organo pharma) | active | — |
| Repatoxaban 2.5 mg Film Coated Tablets | 🇪🇬Egypt | EVAPHARMA for Pharmaceutical Industries ( EVAPHARMA) | active | — |
| Andorivaban 2.5 mg Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
Rivaroxaban 2.5 Mg ; in Africa — Regulatory Overview
Rivaroxaban 2.5 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.